Hypofibrinolytic phenotype in Tsumura Suzuki Obese Diabetes (TSOD) mice unrelated to hyperglycemia

Drug Discov Ther. 2023 Nov 18;17(5):346-350. doi: 10.5582/ddt.2023.01064. Epub 2023 Oct 14.

Abstract

Obesity and diabetes mellitus are associated with increased risk of arterial thrombosis and venous thromboembolism. Tsumura Suzuki Obese Diabetes (TSOD) mice are useful models for elucidating the molecular mechanisms of these diseases. We investigated normoglycemic [Ng]-TSOD mice with a metabolic abnormality that was accompanied by a coagulative and fibrinolytic state with a phenotype that distinctly differed from that of standard TSOD mice. As in TSOD mice, plasminogen activation inhibitor-1 (PAI-1) that inhibits fibrinolysis was substantially augmented in Ng-TSOD mice, suggesting that they are hypofibrinolytic. However, blood clotting parameters were within the normal range in Ng-TSOD mice. These findings indicated that Ng-TSOD mice are novel models with a hypofibrinolytic phenotype that is not associated with hyperglycemia.

Keywords: coagulation; hypofibrinolytic state; obesity; plasma; type 2 diabetes.

MeSH terms

  • Animals
  • Diabetes Mellitus*
  • Hyperglycemia* / complications
  • Mice
  • Mice, Obese
  • Obesity / complications
  • Phenotype